|
Clinical activity and safety of simlukafusp alfa, an engineered interleukin-2 variant targeted to fibroblast activation protein-α, combined with atezolizumab in patients with recurrent or metastatic cervical cancer. |
|
|
Honoraria - Bayer; Daiichi Sankyo; Epizyme; Ipsen; Lilly; Novartis; Roche |
Consulting or Advisory Role - Bayer; Daiichi Sankyo; Epizyme; Immune Design; Lilly; Roche |
Research Funding - AstraZeneca/MedImmune; Bayer; Merck Serono; MSD Oncology; PharmaMar; Roche |
Patents, Royalties, Other Intellectual Property - BMS Brazil |
|
|
Consulting or Advisory Role - Adaptherapy |
Research Funding - Bristol-Myers Squibb |
|
|
Honoraria - Amgen; Bayer; Roche; Sanofi; Vifor Pharma |
Travel, Accommodations, Expenses - Amgen; Bayer; Roche |
|
|
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; GlaxoSmithKline; MSD; PharmaMar; Roche; Tesaro |
Speakers' Bureau - AstraZeneca; GlaxoSmithKline; MSD; PharmaMar; Roche; Tesaro |
Expert Testimony - AstraZeneca; GlaxoSmithKline; MSD; PharmaMar; Roche; Tesaro |
Travel, Accommodations, Expenses - Baxter; GlaxoSmithKline; Roche; Tesaro |
|
|
Consulting or Advisory Role - Actelion (I); Biomarin (I); Brenus Pharma |
Research Funding - Astellas Pharma; Ipsen; Janssen |
Patents, Royalties, Other Intellectual Property - I have a pending patent on a new drug combination for prostate cancer treatment |
Travel, Accommodations, Expenses - Amicus Therapeutics (I); AstraZeneca; AstraZeneca; Biomarin (I); Janssen; MSD; Nutricia (I); Pfizer |
|
|
Employment - Rambam Health Care Campus |
Consulting or Advisory Role - Karyopharm Therapeutics |
Research Funding - Abbvie; Bristol-Myers Squibb; Genentech; Genmab; Incyte; Janssen; Lilly; MSD; NeoTX |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - MSD Oncology (Inst) |
Consulting or Advisory Role - Amgen (Inst); Gen (Inst); Lilly (Inst); Novartis (Inst); Roche |
Speakers' Bureau - MSD Oncology (Inst); Novartis (Inst); Roche (Inst) |
Research Funding - Amgen (Inst) |
Travel, Accommodations, Expenses - Pfizer |
|
|
Consulting or Advisory Role - Astellas Amgen BioPharama; AstraZeneca; Johnson & Johnson; Lilly; Merck; Novartis; Roche; Teva |
Speakers' Bureau - Amgen; Bayer; Bristol-Myers Squibb; Johnson & Johnson; Lilly; Teva |
Research Funding - Amgen; AstraZeneca; Bristol-Myers Squibb; Johnson & Johnson; Lilly; Nektar; Novartis; Roche |
|
|
|
Consulting or Advisory Role - Amgen; CBPartners |
|
|
Employment - Idorsia; Roche |
Stock and Other Ownership Interests - Idorsia; Roche |
|
|
|
Stock and Other Ownership Interests - Roche |
Travel, Accommodations, Expenses - Roche |
|
|
Employment - F. Hoffmann LaRoche |
Stock and Other Ownership Interests - F. Hoffmann LaRoche |
Travel, Accommodations, Expenses - F. Hoffmann LaRoche |
|
|
|
Stock and Other Ownership Interests - Roche |
|
|
No Relationships to Disclose |
|
|
Employment - F. Hoffmann LaRoche |
Stock and Other Ownership Interests - F. Hoffmann LaRoche |
Travel, Accommodations, Expenses - F. Hoffmann LaRoche |
|
|
Employment - Roche Glycart AG |
Stock and Other Ownership Interests - Jazz Pharmaceuticals; Roche |
|
|
|
|
Stock and Other Ownership Interests - Roche |
|
|
|
Travel, Accommodations, Expenses - Roche |
|
|
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD Oncology; Novartis; PFIZER; Roche/Genentech; Seagen; Takeda |
Consulting or Advisory Role - Regeneron |
Travel, Accommodations, Expenses - AstraZeneca; Roche |